Skip to: Content
Skip to: Site Navigation
Skip to: Search
SATURDAY, NOVEMBER 21, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: Lipitor

Lipitor stories: 10 news summaries

Pfizer Offers Free Lipitor, Viagra to Jobless

70 drugs available to those who lost jobs since Jan. 1

May 14, 09 10:27 AM CDT
(AP) - Pfizer is unveiling a new program that will let people who have lost their jobs and health insurance keep taking some of its medications—including Lipitor and Viagra—for free for up to a year. The world’s biggest drugmaker will provide more than 70 of its prescription drugs free... More »

MORE ABOUT:
health care • health insurance • Pfizer • Viagra • unemployment • Lipitor • pharmaceutical industry • jobless • Jay-ZTV

 Novartis Acquires Plavix Rival 

Novartis acquires worldwide rights from a San Francisco biopharmaceutical firm

Feb 12, 09 8:22 AM CST
(Newser) - Novartis AG will pay a San Francisco biopharmaceutical company $75 million—with the potential for an additional $500 million—for the worldwide rights to an experimental anticlotting drug the Swiss drug firm hopes will rival Plavix, reports the Wall Street Journal. Market leader Plavix rang up $8.22 billion... More »

MORE ABOUT:
pharmaceutical companies • Eli Lilly • Lipitor • prasugrel • Plavix • Bristol Myers Squibb • Novartis AG • Portola Pharmaceuticals • elinogrel

 Pfizer to Can 800 Researchers 

Company must cut R&D spending ahead of Lipitor patent expiration

Jan 13, 09 12:19 PM CST
(Newser) - Pfizer will eliminate the jobs of up to 800 researchers in 2009, starting today, the Wall Street Journal reports. The pharmaceutical giant is attempting to cut costs ahead of a $30 billion reduction in revenue expected in 2011 when its patent on the popular cholesterol drug Lipitor expires. But the... More »

MORE ABOUT:
layoffs • pharmaceutical companies • drug companies • Pfizer • research • generic drugs • Lipitor • pharmaceutical industry

GLOSSIES

 2008 Hall of Infamy
Inductees 

A month-by-month gallery of the year's most ignominious figures

Dec 25, 08 8:21 PM CST
(Newser) - As we look back at the great people who made their mark this year, let us not forget to document the schlubby, the sneaky, and the just plain criminal. Vanity Fair has done the legwork, rounding up a month-by-month rogue's gallery. Some highlights:
  • January: Rudy Giuliani's Florida
... More »

MORE ABOUT:
Rudy Giuliani • Robert Mugabe • politics • Eliot Spitzer • Carly Fiorina • Lipitor • Radovan Karadzic • Rod Blagojevich • Mark Penn • scandal • Robert Jarvik • He Kexin • Richard Fuld • Joe the Plumber • Best of 2008

Deal Delays Generic Lipitor Until 2011

Pact with Indian drug maker stands to net billions for Pfizer

Jun 18, 08 5:11 PM CDT
(Newser) - Pfizer has struck a deal with an Indian generic drug maker to delay a cheaper version of Lipitor in the US until November 2011. The agreement limiting generic versions of the cholesterol-lowering drug will translate into billions more in profits for Pfizer, the New York Times reports. Lipitor, the world's... More »

MORE ABOUT:
pharmaceutical companies • Pfizer • cholesterol lowering drug • Lipitor • pharmaceutical industry

Congress
to Probe 'Misleading' Drug Ads

Cholesterol, anemia drugs in spotlight

May 8, 08 3:10 AM CDT
(Newser) - A congressional panel will examine three ad campaigns as part of a move to tighten regulations on drug companies' direct-to-consumer marketing, the Wall Street Journal reports. The committee will focus on ads for cholesterol drugs Vytorin and Lipitor, and anemia drug Procrit, which has been promoted as an anti-fatigue drug... More »

MORE ABOUT:
drugs • advertising • Merck • drug companies • Pfizer • Johnson and Johnson • congressional Democrats • Lipitor • Bart Stupak • Vytorin • Schering-Plough

Pfizer Pulls Lipitor Ads
After Probe

Critics accused
pharma giant of
inflating doctor's CV

Feb 25, 08 7:55 PM CST
(Newser) - Pfizer said today it will drop its ads for cholesterol drug Lipitor due to criticisms of the TV spots, the New York Times reports. US lawmakers recently probed whether the campaign had inflated the credentials of artificial heart developer Dr. Robert Jarvik. "The way in which we presented Dr.... More »

MORE ABOUT:
pharmaceutical companies • Pfizer • Lipitor • Robert Jarvik

Prices Jump for Top Drugs

Drug giants collect now against expected future losses

Feb 21, 08 4:45 AM CST
(Newser) - Drug companies have slapped a series of huge price hikes on some prescription drugs ahead of drug patent expirations, the Wall Street Journal reports. GlaxoSmithKline has raised the price of antidepressant Wellbutrin 44.5%, while Sanofi-Aventis hiked Ambien's price 70%. Wholesale prices for the top 50 drugs increased an average... More »

MORE ABOUT:
Barack Obama • Hillary Clinton • John McCain • antidepressant • drug companies • GlaxoSmithKline • Pfizer • health insurance premiums • price increases • health care reform • Centers for Medicare and Medicaid Services • Lipitor • pharmaceutical industry • co-pays • Ambien • Wellbutrin • Adderall XR • Sanofi-Aventis • Shire • patent expiration

Big Pharma Faces Big Plunge

Profits will drop as patents expire, and chemical-based therapies are eclipsed by biotech

Dec 6, 07 4:50 AM CST
(Newser) - Patent protections on some of the pharmaceutical industry's best-selling drugs, like Lipitor, Plavix and Singulair, are due to expire in the next several years, and drug manufacturers have little in the pipeline to replace them. The drug companies will lose billions—as much as half their combined revenue—to generic... More »

MORE ABOUT:
Merck • pharmaceutical companies • GlaxoSmithKline • Pfizer • Eli Lilly • Zocor • Lipitor • Plavix • pharmaceutical industry • Zyprexa • Fosamax • Singulair • Cozaar • torcetrapib • drug manufacturer

Battle Brews in Pharma's Market

Pfizer launches attack on generic drug that threatens Lipitor's dominance

Nov 3, 07 6:43 PM CDT
(Newser) - Pfizer is trying to stave off its own heart attack now that its flagship cholesterol-lowering drug Lipitor faces stiff competition from a cheaper generic. Lipitor is still patent-protected, but a very similar drug called Zocor isn't, and since a generic version called simvastatin hit the market, many doctors and insurers... More »

MORE ABOUT:
insurance companies • pharmaceutical companies • Pfizer • cholesterol • health care industry • heart attack • medical treatment • statins • LDL • generic drugs • Zocor • Lipitor • simvastatin

10 Stories


from our news partners